The use of baker's yeast in the generation of asymmetric centers to produce chiral drugs and others compounds

Critical Reviews in Biotechnology

Volumn 18, Issue 1, 1998, Pages 25-64

  De Souza Pereira, Ricardo ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Asymmetric synthesis; Baker's yeast; Biotransformation; Organometallics; Saccharomyces cerevisiae

Indexed keywords

3 HYDROXYBUTYRIC ACID; ALCOHOL DEHYDROGENASE; ATOMOXETINE; BENZALDEHYDE; BETA LACTAM ANTIBIOTIC; CARNITINE; DENOPAMINE; DILTIAZEM; EPHEDRINE; FENFLURAMINE; FLUOXETINE; IBUPROFEN; LACTATE DEHYDROGENASE; LANOSTEROL SYNTHASE; ORGANOMETALLIC COMPOUND; PENICILLAMINE; PYRUVIC ACID; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; TERPENE DERIVATIVE; THALIDOMIDE; THIAMINE; VERAPAMIL;

BIOTRANSFORMATION; CHIRALITY; COST CONTROL; CYCLIZATION; DRUG SYNTHESIS; ENZYME ACTIVE SITE; ENZYME MECHANISM; PRIORITY JOURNAL; REVIEW; SACCHAROMYCES CEREVISIAE; STEREOISOMERISM; TERATOGENICITY;

SACCHAROMYCES CEREVISIAE;

EID: 0031919013     PISSN: 07388551     EISSN: None     Source Type: Journal    
DOI: 10.1080/0738-859891224211     Document Type: Review

References (86)

1. Ariens, E.J. 1988. Stereospecificity in Bioactive Agents , Elsevier, Amsterdam, pp 39.
2. Banfi, L., Cascio, G., Ghiron, C., Guanti, G., Manghisi, E., Narisano, E. and Riva R. 1994. Microbiological enantioselective synthesis of (S) and (R) 4-(p-anisyloxy)-3-hydroxybutirates as new chiral building blocks for the synthesis of β-lactam antibiotics. Tetrahedron, 50: 11983-11994.
3. Bar, R. 1989. Cyclodextrin-aided microbial transformation of aromatic aldehydes by Saccharomyces cerevisiae. Appl. Microbiol. Biotechnol., 31: 25-28 .
4. Bare, G. 1991. Jacques, P.H., Hubert, J.B., Rikir, R. and Thonart, P.H.: Bioconversion of a L-carnitin precursor in a one-or two-phase system. Appl. Biochem. Biotechnol., 28/29: 445-456.
5. Belan, A., Bolte, J., Fauve, A., Gourcy, J.G. and Veschambre, H. 1987. Use of biological systems for the preparation of chiral molecules. 3. An application in pheromone synthesis: preparation of sulcatol enantiomers. J. Org. Chem., 52: 256-260.
6. Binning, G., Gerber, Ch., Stoll, E., Albrecht, T.R. and Quate, C.F. 1987. Atomic resolution with atomic force microscope. Europhys. Lett., 3: 1281.
7. Binning, G., Quate, C.F. and Gerber Ch. 1986. Atomic Force Microscopy. Phys. Rev. Lett., 56: 930-933.
8. Brown, H.C. and Pai, G.G. 1983. Asymmetric reduction of prochiral α-halo ketones with β-3-pinanyl-9-borabicyclo [3.3.1]-nonane. J. Org. Chem., 48: 1784-1786.
9. Brown, H.C. and Ramachandran, P.V. 1995. Versatile α-pinene-based borane reagents for asymmetric syntheses. J. Organometallic Chem., 500: 1-19.
10. Brown, H.C., Ramachandan, P.V., Weissman, S.A. and Swaminathan, S. 1990. Selective reductions. 46. Effect of the steric requirement at the 2-position of apopinene on chiral reductions. B-(iso-2-ethylapopinocampheyl-) and β-(iso-2-n-propylapopinocampheyl)-9-borabicyclo [3.3.1] nonanes as improved reagents for the chiral reduction of a, β-acetylenic ketones and α-keto esters. J. Org. Chem., 55: 6328-6333 .
11. Brown, R.F., Jackson, W.R. and McCarthy, T.D. 1993. A synthesis of (-)-denopamine. Tetrahedron Asym., 4: 2149-2150 .
12. Bujons, J., Guajardo, R. and Kyler, K.S. 1988. Enantioselective enzymatic sterol synthesis by ultrasonically stimulated baker's yeast. J. Am. Chem. Soc., 110: 604-606 .
13. Carvalho, M., Okamoto, M.T., Morán, P. J. S. and Rodrigues, J.A.R. 1991. Baker's yeast reduction of α-haloacetophenones. Tetrahedron, 12/13: 2073 -2080.
14. Castilho, R.F., Pereira, R.S. and Vercesi A. E. 1996. Protective effect of safranine on the mitochondrial damage induced by Fe(II) citrate: comparative study with trifluoperazine. Eur. J. Drug Metab. Ph., 21: 17-21.
15. Chen, C.S. and Sih, C.J. 1989. General aspects and optimization of enantioselective biocatalysis in organic solvents: the use of lipases. Angew. Chem. Int. Ed. Engl., 28: 695.
16. Chênevert, R. and Fortier, G. 1991. Chemoenzymatic synthesis of both enantiomers of fluoxetine, Chem. Lett., 1603-1606 .
17. Chênevert, R., Geneviève, F. and Rhlid, R.B. 1992. Asymmetric synthesis of both enantiomers of fluoxetine via microbiological reduction of ethyl benzoylacetate, Tetrahedron, 48: 6769-6776 .
18. Chibata, I., Tosa, T, Sato, T. 1974. Immobilized aspartase-containing microbial cells: preparation and enzymatic properties. Appl. Microbiol., 27: 878-885.
19. Chow, Y.S., Shin, H.S., Adesina, A.A. and Rogers, P.L. 1995. A kinetic model for the deactivation of pyruvate decarboxylase (PDC) by benzaldehyde. Biotechnol. Lett., 17: 1201-1206 .
20. Corey, E.J. and Link, J.O. 1990. The first enantioselective syntheses of pure R- and S-isoproterenol. Tetrahedron Lett., 31: 601-604 .
21. Corey, E.J. and Link, J.O. 1991. A catalytic enantioselective synthesis of denopamine, a useful drug for congestive heart failure. J. Org. Chem., 56: 442-444 .
22. Crout, D.H.G., Dalton, H., Hutchinson, D.W. and Miyagoshi, M. 1991. Studies on pyruvate decarboxylase: acyloin formation from aliphatic, aromatic and heterocyclic aldehydes. J. Chem. Soc. Perkin Trans. 1, 1329-1334 .
23. Crumble, R.L., Deol, B.S., Nemorin, J.E., and Ridley, D.D. 1978. Asymmetric reduction of carbonyl compounds by yeast. IV. Preparation of optically active β-hydroxy sulfides, sulfoxides and sulfones. Aust. J. Chem., 31: 1965-1980.
24. Csuk, R. and Glänzer, B.I. 1991. Baker's yeast mediated transformations in organic chemistry. Chem. Rev., 91: 49-97.
25. Cunningham, E.B. 1978. Mechanisms of Metabolism, Mc-Graw-Hill, New York, pp 526.
26. Darnet, S., Thomas, D. and Legoy, M. 1993. Use of enzymatic oxygen scavangers to prevent lactate dehydrogenase inactivation by oxygen radicals. Enzyme Microb. Technol., 15: 8-12.
27. Dziezak, J.D. 1987. Yeasts and yeast derivatives: definitions, characteristics, and processing. Food Technol., 41: 104-121.
28. Ebbesen, P. 1991. Chirality of quartz. Fibrosis and tumour development in dust inoculated mice. Eur. J. Cancer Prev., 1: 39-41.
29. Fantin, G., Fogagnolo, M., Guerzoni, M.E., Medici, A., Pedrini, P. and Poli, S. 1994. Stereochemical control in baker's yeast redox biotransformations of aryl methyl ketones and carbinols. J. Org. Chem., 59: 924-925.
30. 2H] propiophenone, (R)-fluoxetine, and (R)- and (S)-fenfluramine. J. Org. Chem. 56: 6019-6023.
31. Gill, G., Ferre, E., Barre, M., and Le Petit, J. 1988. Reduction of allenic alcohols by Saccharomyces cerevisiae. Tetrahedron Lett., 29: 3797.
32. Goodman, L.S. and Gilman, A. 1991. As Bases Farmacológicas da Terapêutica, Guanabara Koogan, 8a. ed., pp 140.
33. Greenberg, M.J. 1979. Dependence of odor intensity on the hydrophobic properties of molecules. A quantitative structure odor intensity relationship. J. Agric. Food Chem. , 27: 347-352.
34. Hilderbrandt, G. and Klavehn, W. 1930. Ger. Pat. , 548.459.
35. Jaeschke, H., Kleinwaechter, C., and Wendel, A. 1987. The role of acrolein in allyl alcohol-induced lipid peroxidation and liver cell damage in mice. Biochem. Pharmacol., 36: 51-57.
36. Jian-Xin, G., Zu-Yi, L. and Guo-Qiang, L. 1993. Reductive biotransformation of carbonyl compounds - Application of fungus, Geotrichum sp G38 in organic synthesis. Tetrahedron, 49: 5805-5816.
37. Kamal, A., Rao, M.V. and Rao, A.B. 1990. Enzymatic cyclizations mediated by ultrasonically stimulated baker's yeast: synthesis of imidazofused heterocycles. J. Chem. Soc. Perkin Trans. I, 10: 2755-2757.
38. Kawaguchi, T., Saito, K., Matsuki, K., Iwakuma, T. and Takeda, M. 1993. Asymmetric reduction of aromatic ketones. I. Enantioselective synthesis of denopamine. Chem. Pharm. Bull., 41: 639-642.
39. Koenig, T.M. and Mitchell, D. 1994. A convenient method for preparing enatiomerically pure norfluoxetine, fluoxetine and tomoxetine. Tetrahedron Lett, 35: 1339-1342.
40. Kumar, A., Ner, D.H. and Dike, S. 1992. A novel chemoenzymatic enantioselective synthesis of some clinically effective CNS drugs and related-compounds. Indian J. Chem., 31B: 803-809.
41. Long, A and Ward, O.P. 1989. Biotransformation of benzaldehyde by Saccharomyces cerevisiae: characterization of the fermentation and toxicity effects of substrates and products. Biotechnol. Bioeng., 34: 933-941.
42. Mackworth, J. F. 1948. The inhibition of thiol enzymes by lachrymators. Biochem. J., 42: 82-90.
43. MacLeod, R., Prosser H., Fikentscher, L., Lanyi, J. and Mosher, H.S. 1964. Asymmetric reductions. XII. Stereoselective ketone reductions by fermenting yeast. Biochemistry, 3: 838-846.
44. Matsumae, H., Douno, H., Yamada S., Nishida, T., Ozaki Y., Shibatani, T. and Tosa T. 1995. Microbial asymmetric reduction of (RS)-2-(4-methoxyphenyl)-1,5-benzothiazepin-3,4(2H,5H)-dione, the key intermediate in the synthesis of diltiazem hydrochloride. J. Ferm. Bioeng., 79: 28-32.
45. Medina, J.C. and Kyler, K.S. 1988. Enzymatic cyclization of hydroxylated surrogate squalenoids with baker's yeast. J. Am. Chem. Soc., 110: 4818-4821.
46. Mogren, H., Hedenskog, G. and Hofsten, A. 1973. The influence of heat processing and mechanical desintegration on yeast for single-cell protein. Physiol. Plant., 29: 82-91.
47. Mori, K. 1989. Synthesis of optically active pheromones. Tetrahedron, 45: 3233-3298.
48. a edição, Fundação Calouste Gulbenkian. pp. 159 .
49. Nakamura, K., Inoue, K., Ushio, K., Oka, S., and Ohno, A. 1987. Effect of allyl alcohol on reduction of β-keto esters by baker's yeast. Chem. Lett.,4: 679-682.
50. Nakamura, K., Kawai, Y., Nakajima, N., and Ohno, A. 1991. Stereochemical control of microbial reduction 17. A method for controlling the enantioselectivity of reductions with baker's yeast. J. Org. Chem., 56: 4778-4383.
51. Nikolova, P. and Ward, O.P. 1991. Production of L-Phenylacetyl carbinol by biotransformation: product and by-product formation and activities of the key enzymes in wild-type and ADH isoenzyme mutants of Saccharomyces cerevisiae. Biotechnol. Bioeng., 20: 493-498.
52. Pampulha, M.E. and Loureiro-Dias, M.C. 1989. Combined effect of acetic acid, pH and ethanol on intracellular pH of fermenting yeast. Appl. Microbiol. Biotechnol., 31: 547-550.
53. Parascandola, P. and Dealteriis, E. 1996. Pattern of Growth and Respiratory Activity of Saccharomyces cerevisiae (baker's yeast) cells growing entrapped in an insolubilized gelatin gel. Biotechnol. Appl. Biochem., 23: 7-12.
54. Pereira, R.S. 1995a. Baker's yeast: some biochemical aspects and their influence in biotransformations. Appl. Biochem. Biotechnol., 55: 123-132.
55. Pereira, R.S. 1995b. Biological fermentation of baker's yeast (Saccharomyces cerevisiae) and its use in asymmetric synthesis. Quím. Nova, 18: 452-459.
56. 2+ and protection by calcinine. Eur. J. Drug Metab. Ph., 21: 23-26.
57. Pereira, R.S. 1998. Comparison of biochemical effects produced by calcium ions and by monomers of polyacrylamide (acrylamide and bisacrylamide) on strains of Saccharomyces cerevisiae used for production of chiral synthons. Mol. Cell. Biochem., 178: 33-40.
58. Pereira, R.S. 1997. Project and construction of a reactor for reactions catalyzed by baker's yeast (Saccharomyces cerevisiae). Quím. Nova, 20: 551-554.
59. ++ plus prooxidants. Biochem. Pharmacol., 44: 1795-1801.
60. Pereira, R.S. and Durán N. 1996. Variable influence of ferric and cupric ions on Saccharomyces cerevisiae strains used in asymmetric organic synthesis. Biotechnol. Lett., 18: 857-862.
61. Pereira, R.S. and Hermes-Lima, M. 1996. Can trifluoperazine protect mitochondria against reactive oxygen species? Eur. J. Drug Metab. Ph., 21: 281-284.
62. Pereira, R.S., Parizotto, N.A. and Baranauskas, V. 1996. Observation of baker's yeast strains used in biotransformation by atomic force microscopy. Appl. Biochem. Biotechnol., 59: 135-143.
63. Pereira, R.S., Pavão, F. and Oliva, G. 1997. The use of molecular modelling in the understanding of configurational specificity (R or S) in asymmetric reactions catalyzed by Saccharomyces cerevisiae or isolated dehydrogenases. Mol. Cell. Biochem., 178: 27-31.
64. Pollack, J.W., Jacobs, J.W. and Schultz, P.G. 1986. Selective chemical catalysis by an antibody. Science, 234: 1570-1573.
65. Präve, P., Faust, U., Sittig, W. and Sukatsch, D.A. 1987. Fundamentals of Biotechnology, VCH publishers, Weinheim, 563-600.
66. Prudent, J.R., Uno T. and Schultz, P.G. 1994. Expanding the scope of RNA catalysis. Science, 264: 1924-1927.
67. Ramachandran, P.V., Brown, H.C. and Swaminathan, S. 1990. Lithium-B-iso-2-ethylapopinocampheyl-9-borabicyclo [3.3.1] nonylhydride as an improved reagent for asymmetric reduction of unhindered aliphatic ketones. Further evidence for the improved enantioselectivity in reductions by reagents containing increased steric requirements at the 2-position of the apopinene structure. Tetrahedron Asymmetry, 1: 433-436.
68. Rao, K.R., Nageswar Y.V.D. and Sampathkumar H.M. 1990. Biocatalytic asymmetric cycloaddition of benzonitrile N-oxides to N-vinylcarbazole. J. Chem. Soc. Perkin Trans. I, 11: 3199.
69. Rawn, D. 1989. Biochemistry, International Edition, Neil Petterson Publishers, 265-287.
70. Schauenstein, E., and Esterbauer, H. 1979. Formation and properties of reactive aldehydes In: Submolecular Biology and Cancer, Ciba Foundation Series 67, Excerpta Medica, Amsterdam, 225-244.
71. Schultz, P.G. 1989. Catalytic antibodies. Angew. Chem. Int. Ed. Engl., 28: 1283.
72. Seebach, D., Sutter, M.A., Weber, R.H. and Zuger, M.F. 1984. Yeast reduction of ethyl acetoacetate: (S)-(+)-ethyl 3 hydroxybutanoate. Org. Synth., 63: 1-9.
73. Shin, H.S. and Rogers, P.L. 1996. Production of L-phenylacetylcarbinol (L-PAC) from benzaldehyde using partially purified pyruvate decarboxylase (PDC). Biotechnol. Bioeng., 49: 52-62.
74. Singer, Y., Shity, H. and Bar R. 1991. Microbial transformation in a cyclodextrin medium. Part 2. Reduction of androstenedione to testosterone by Saccharomyces cerevisiae. Appl. Microbiol. Biotechnol. 35: 731-737.
75. Sorrilha, A. E. P. M., Marques, M., Joekes, L, Morán, P. J. S. and Rodrigues J. A. R. 1992. Reduction of phenylketones by immobilized baker's yeast. Bioorg. Med. Chem. Lett., 2: 191-196.
76. Stinson, S.C. 1993. Chiral drugs. Chem. Eng. News, 71: 38-65.
77. Stinson, S.C. 1994. Chiral drugs. Chem. Eng. News, 72: 38-72.
78. Ushio, K., Ebara, K., and Yamashita, T. 1991. Selective inhibition of R-enzymes by simple organic acids in yeast-catalysed reduction of ethyl 3-oxobutanoate. Enzyme Microb. Technol., 13: 834-839.
79. Utaka, M., Konishi, S., Mizuoka, A., Ohkubo, T., Sakai, T., Tsuboi, S. and Takeda, A. 1989. Asymmetric reduction of the prochiral carbon-carbon double bond of methyl 2-chloro-2-alkenoates by use of fermenting baker's yeast. J. Org. Chem., 54: 4989-4992.
80. Vives, C., Casas, C., Gòdia, F. and Solà, C. 1993. Determination of the intrinsic fermentation kinetics of Saccharomyces cerevisiae cells immobilized in Ca-alginate beads and observations on their growth. Appl. Microbiol. Biotechnol., 38: 467-472.
81. Voet, D and Voet J.G. 1990. Biochemistry, John Wiley and Sons, pp 445.
82. Ward, O.P. 1995. Application of baker's yeast in bioorganic synthesis. Can. J. Bot., 73:S1043-S1048.
83. Ward, O.P. and Young, C.S. 1990. Reductive biotransformations of organic compounds by cells or enzymes of yeast. Enzyme Microb. Technol., 12: 482-493.
84. Weijers, C.A.G.M., Litjens, M.J.J. and de Bont, J.A.M. 1992. Synthesis of optically pure 1,2-epoxypropane by microbial asymmetric reduction of chloroacetone. Appl. Microbiol. Biotechnol. , 38: 297-300.
85. Zhou, B.N., Gopalan, A.S., VanMiddlesworth, F., Shieh, W.R. and Sih, C. J. 1983. Stereochemical control of yeast reductions. 1. Asymmetric synthesis of L-carnitine. J. Am. Chem. Soc., 105: 5925-5926.
86. Zyla, K. 1994. Phytate dephosphorylation by free and immobilized cells of Sacharomyces cerevisiae. J. Ind. Microbiol., 413: 30-34.